Brian K. Halak

Partner at Domain Associates LLC

Brian K. Halak

Brian K. Halak

Partner at Domain Associates LLC

Overview
Career Highlights

Windmil Therapeutics, Inc.

RelSci Relationships

1912

Number of Boards

34

Birthday

1972

Age

47

Contact Data
Trying to get in touch with Brian K. Halak? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Brian K. Halak likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Domain Associates LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Founder at Domain Associates LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Managing Director at Alta Partners Management Corp.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Founder at Carticept Medical, Inc.

Relationship likelihood: Strong

Co-Founder at Alimera Sciences Inc.

Relationship likelihood: Strong

Co-Founder at Alimera Sciences Inc.

Relationship likelihood: Strong

Founder & Managing Director, Questa Capital at Medrio, Inc.

Relationship likelihood: Strong

Paths to Brian K. Halak
Potential Connections via
Relationship Science
You
Brian K. Halak
Partner at Domain Associates LLC
Education
Ph.D Immunology
Class of 2000

With several research centers, an extensive health system and nearly 200 years of history, Thomas Jefferson University (TJU) is one of the premier medical schools in the United States. The university divides its academics and research into six schools and colleges: * College of Graduate Studies * Medical College * School of Health Professions * School of Nursing * School of Pharmacy * School of Population Health These academic divisions provide support for every area of study in health and medicine, from Biomedical Science to Public Health. Graduate certificates, master’s degrees and doctoral degrees are available, and the School of Nursing offers many baccalaureate programs, as well. Because of the wide range of programs available, admissions procedures vary at Thomas Jefferson University. For example, in the College of Graduate Studies, the deadline for PhD applications is January 5, while applications for the MS program are accepted throughout the year. Similarly, each TJU school has its own FAFSA code, so make sure to use the right one when you apply for financial aid. Though opportunities vary by program, all TJU schools offer a combination of state, federal, and institutional grants, scholarships and fellowships to help you manage the cost of tuition for your program.

BSE
Class of 1993

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Career History
Partner
2001 - Current

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

Managing Member
Current
Advisor
Current

Elm Street Ventures focuses on seed and early-stage investments in life sciences companies that are formed based on intellectual property developed at Yale University and other research institutions in the region of the US consisting of New York City and Southern New England. They target investments in the following fields: therapeutics, medical devices, diagnostics, research tools/services, materials, healthcare information technology and healthcare services. The firm looks for companies with exceptional management teams, attractive markets, solid patent protection/freedom to operate and defensible market positions. Investments range from several hundred thousand dollars to several million dollars, with substantial capital reserved for follow-on investments. Elm Street Ventures typically invests in syndicate with other institutional investors.

Boards & Committees
Member, Strategic Advisory Board
Current

PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. It focuses on clinical research on innovative anti-atherosclerotic medicinal product, production of innovative dermatological products, and introduction of innovative dietary supplement used for special nutritional needs in the prevention of atherosclerosis. It distributes its products under the Menavitim, Dermena, Allerco, and Thermi brands. The company was founded by Jerzy Gebicki on November 12, 2002 and is headquartered in Lodz, Poland.

Director
Current

SMART Medical Systems Ltd. manufactures medical devices. The firm's products include naviaid platform, G-EYE, naviaid AB, naviaid ABC, inflation systems, controlled withdrawal nd future naviaid products. The company was founded by Gadi Terliuc in 205 and is headquartered in Ra'anana, Israel.

Director
Current
Member, Investment Advisory Council
Current

Ben Franklin Technology Partners of Southeastern Pennsylvania engages in investment and advisory services. It provides capital to information technology, health, manufacturing, energy, and physical sciences industries. The company is headquartered in Philadelphia, PA.

Advisor
Prior

Ben Franklin Technology Partners (BFTP) provides seed and early-stage capital to companies in the information technology, life sciences and physical sciences sectors. Their Innovation Fund provides up to $100,000 to technology companies for prototype refinement and/or very early commercialization efforts. BFTP's Emerging Fund invests up to $750,000 in technology companies over multiple financing rounds for product or process development and/or commercialization efforts. Their Technology Commercialization Fund invests up to $350,000 in select university and research institution spin-out companies. Companies must be commercial, for-profit businesses located in the Pennsylvania counties of Buck, Chester, Delaware, Montgomery or Philadelphia.BFTP provides early-stage financing to promising life sciences ventures in the biopharmaceuticals, medical devices, diagnostics, biomaterials and healthcare information technology industries. They look for companies with strong management and strong IP and patent protection that are involved in a novel and unique science. Investments range from $100,000 to $500,000 as part of larger funding rounds of $200,000 to $3 million involving other sources such as SBIR, angel, early-stage venture capital and other state funding sources.BFTP also invests in promising physical sciences companies involved in developing advanced materials, sensors, robotics, environmental and consumer goods. They look for companies with strong management and strong IP and patent protection that offer a disruptive and unique technology.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $999
2016

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

$1,000 - $2,499
2015

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

$1,000 - $2,499
2014

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Political Donations
$2,142
2011
$2,000
2010
$2,000
2009
Transactions
Details Hidden

Windmil Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Windmil Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Domain Partners VIII LP raised money in a private placement transaction

Investments
Details Hidden

Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA.

Details Hidden

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian K. Halak. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian K. Halak's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian K. Halak.